Omeros Corporation
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.3M
Doctors Paid
4,299
Transactions
10,296
2021 Total
$1.6M
Payment Breakdown by Category
Research$2.8M (53.8%)
Consulting$1.4M (26.7%)
Food & Beverage$256,920 (4.9%)
Travel$105,922 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.8M | 249 | 53.8% |
| Consulting Fee | $1.4M | 455 | 26.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $357,914 | 141 | 6.8% |
| Food and Beverage | $256,920 | 8,990 | 4.9% |
| Honoraria | $238,732 | 81 | 4.5% |
| Travel and Lodging | $105,922 | 360 | 2.0% |
| Education | $66,607 | 19 | 1.3% |
| Grant | $3,000 | 1 | 0.1% |
Payments by Type
Research
$2.8M
240 transactions
General
$2.4M
10,047 transactions
Ownership
$0
9 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| OMS721-GNP-001 | $1.2M | 15 | 150 |
| An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients | $636,578 | 0 | 24 |
| OMS 721-TMA-001 | $295,119 | 0 | 10 |
| A Retrospective Study to Determine the Incidence of, Risk Factors for, and Outcomes of Patients with Transplant-Associated Thrombotic Microangiopathy (TA-TMA) After Allogeneic Hematopoietic Cell Transplantation | $268,900 | 0 | 11 |
| OMS302-ILR-007 | $101,490 | 0 | 21 |
| Pain Control and Reduction in Opioid Use | $50,000 | 0 | 2 |
| Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 | $31,549 | 0 | 2 |
| OMS721-TMA-001 | $16,076 | 0 | 15 |
| OMS824-HTD-002 | $2,122 | 0 | 1 |
| OMS182399 | $700.00 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 8
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Dr. Alan Shuster, M.d, M.D | Ophthalmology | Jupiter, FL | $336.36 | $0 |
| Dr. Matthew Boyer, Md, MD | Ophthalmology | Evansville, IN | $335.28 | $0 |
| Dr. James Chen, M.d., M.p.h, M.D., M.P.H | Sports Medicine | San Francisco, CA | $328.33 | $0 |
| Philip Desouza, Md, MD | Internal Medicine | Sacramento, CA | $327.48 | $0 |
| Dr. Alexander Voldman, D.o, D.O | Ophthalmology | Milford, CT | $320.71 | $0 |
| Dr. Bryan Jefferies, Md, MD | Ophthalmology | Marietta, GA | $319.49 | $0 |
| Dr. Subir Paul, M.d, M.D | Internal Medicine | Florence, AL | $319.01 | $0 |
| Kenneth Lock, D.o, D.O | Anesthesiology | Warren, MI | $314.77 | $0 |
| Kristopher Pugh, M.d, M.D | Ophthalmology | Jeffersonville, IN | $309.54 | $0 |
| Dr. Randal Pham, M.d, M.D | Specialist | San Jose, CA | $302.30 | $0 |
| Dr. Walter Egenmaier, O.d, O.D | Optometrist | Evansville, IN | $297.40 | $0 |
| Richard Cape, Md, MD | Ophthalmology | Dyersburg, TN | $295.45 | $0 |
| Dr. Kathryn Hecker, Md, MD | Ophthalmology | Greensboro, NC | $293.09 | $0 |
| Michael Patterson, D.o, D.O | Ophthalmology | Crossville, TN | $287.67 | $0 |
| Douglas Buxton, Md, MD | Ophthalmology | New York, NY | $287.17 | $0 |
| Dr. John Oltean, Do, DO | Ophthalmology | Muskegon, MI | $285.21 | $0 |
| Thomas Tann, Md, MD | Ophthalmology | Oxford, MS | $284.22 | $0 |
| Maria Scott, M.d, M.D | Ophthalmology | Annapolis, MD | $284.08 | $0 |
| Dr. Andrew Esposito, Md, MD | Ophthalmology | Cleveland, OH | $283.35 | $0 |
| Prashant Parekh, M.d., M.b.a, M.D., M.B.A | Ophthalmology | Miami, FL | $280.34 | $0 |
| Dr. Robert Casanova, M.d, M.D | Ophthalmology | Opelousas, LA | $279.52 | $0 |
| Damien Macaluso, Md, MD | Ophthalmology | Asheville, NC | $271.42 | $0 |
| Dr. Roger Luskind, M.d, M.D | Ophthalmology | Middletown, CT | $270.72 | $0 |
| David Brear | Ophthalmology | Culpeper, VA | $270.39 | $0 |
| Konrad Filutowski, M.d.,, M.D., | Ophthalmology | Lake Mary, FL | $270.06 | $0 |
Ad
Top Products
- Omidria $1.3M
- OMIDRIA $738,978
Associated Products (4)
- Omidria $1.6M
- OMIDRIA $896,672
- Narsoplimab $391,825
- narsoplimab $84,617
Payment Categories
- Food & Beverage $256,920
- Consulting $1.4M
- Travel & Lodging $105,922
- Research $2.8M
About Omeros Corporation
Omeros Corporation has made $5.3M in payments to 4,299 healthcare providers, recorded across 10,296 transactions in the CMS Open Payments database. In 2021, the company paid $1.6M. The top product by payment volume is Omidria ($1.3M).
Payments were distributed across 87 medical specialties. The top specialty by payment amount is Ophthalmology ($1.5M to 2,549 doctors).
Payment categories include: Food & Beverage ($256,920), Consulting ($1.4M), Research ($2.8M), Travel & Lodging ($105,922).
Omeros Corporation is associated with 4 products in the CMS Open Payments database, including Omidria, OMIDRIA, and Narsoplimab.